Dusseldorf [Germany], October 27 (ANI/PRNewswire): Gerresheimer AG, a leading provider of healthcare solutions and drug delivery systems for pharma, biotech and cosmetics and Merck, Darmstadt, a leading science and technology company, jointly developed a digital twin solution to further ensure traceability and trust in crucial steps along the pharmaceutical supply chain. The proof of concept aims to transform the pharma supply chain by creating digital twins for primary packaging. Through a single interconnected network, participants will benefit from full traceability and digital trust, resulting in cost savings, improved quality and even new business models, thanks to process automation.
Ohio [US], March 5 (ANI): By adding an immunotherapy drug to the standard of care treatment regimens, the survival rates for head and neck cancer patients with intermediate-risk features increased, suggests a recently conducted clinical trial by the University of Cincinnati.
Ohio [US], March 1 (ANI): A recently conducted clinical trial by the University of Cincinnati showed that by adding an immunotherapy drug to the standard of care treatment regimens, the survival rates for head and neck cancer patients with intermediate-risk features has increased.
Washington [US], December 23 (ANI): The US Food and Drug Administration (FDA) on Thursday said that it has granted an emergency use authorization for Merck's antiviral pill Molnupiravir that is used to treat COVID-19 patients.
Washington [US], November 20 (ANI): The findings of a study of health records from 87 health care centres across the United States have shown that people taking a class of antidepressants called selective serotonin reuptake inhibitors (SSRIs) were less likely to die due to COVID-19.
Washington [US], November 16 (ANI): A new study of health records from 87 health care centres across the United States found that people taking a class of antidepressants called selective serotonin reuptake inhibitors (SSRIs) were less likely to die of COVID-19.
Seoul [South Korea], November 9 (ANI/Global Economic): A new type of COVID-19 treatment developed overseas will be imported into Korea from February next year.
Rome [Italy], November 5 (ANI/Sputnik): Italy will purchase UK-approved antiviral drug molnupiravir for the treatment of COVID-19, Franco Locatelli, coordinator of the Italian Scientific and Technical Committee on Vaccination, said on Friday.
Canberra [Australia], October 4 (ANI/Sputnik): Australia will purchase 3,00,000 courses of the developmental oral treatment against COVID-19, Molnupiravir, if it is approved by the Therapeutic Goods Administration (TGA), Australian Prime Minister Scott Morrison said on Monday.
Merck & Co said Friday that its experimental COVID-19 pill reduced hospitalisations and deaths by half in people recently infected with the coronavirus and that it would soon ask health officials in the US and around the world to authorize its use. If cleared, Merck’s drug would be the first pill shown to treat COVID-19, […]
\
\
\
\
\
\
\
\
\
\
\
\
\
\
\
\
\
\
\
\
